November 18, 2017  Last Update: December 21, 2016, 11:10 pm

Endo Pharmaceuticals Opiate Products Alert

Endo Pharmaceuticals provides a "Visual Guide" for pill identification, including Opana, Opana ER, Percocet, and other opiate prescription drugs. link is below.

The FDA has issued a Public Health Advisory for anyone possessing opiate prescription medications manufactured by Endo Pharmaceuticals. Please check your meds.

Packaging and manufacturing problems at an inspected plant in Nebraska are responsible.

Over the counter (OTC) products from Novartis are also effected, and there is a separate recall in effect for over the counter medications NoDoz, Bufferin, Excedrin, and Gas-X.

Reports suggest that improper maintenance of equipment and internal processes may allow contamination between products manufactured and packaged on the same equipment, including the packaging of pills.

The FDA wants everyone to make sure they only received the proper medication inside their packages. Several over the counter medications manufactured at the same plant have been recalled (see Novartis recall), due to the cross contamination risk.

In most cases, consumers are provided their prescription pills by a pharmacist. Normal proper pharmacy procedures inspect pills when they are dispensed, so it should be unlikely that the manufacturing problems caused errors that reach consumers.

The following products should be carefully inspected, to be sure that they do not contain a mix of medications:

  • Opana ER (oxymorphone hydrochloride) Extended-Release Tablets CII
  • Opana (oxymorphone hydrochloride) CII
  • Oxymorphone hydrochloride Tablets CII
  • PERCOCET (oxycodone hydrochloride and acetaminophen USP) Tablets CII
  • PERCODAN (oxycodone hydrochloride and aspirin, USP) Tablets CII
  • ENDOCET (oxycodone hydrochloride and acetaminophen USP) Tablets CII
  • ENDODAN (oxycodone hydrochloride and aspirin, USP) Tablets CII
  • MORPHINE SULFATE Extended-Release Tablets CII
  • ZYDONE (hydrocodone bitartrate/acetaminophen tablets, USP) CIII

Reports suggest that improper maintenance of equipment and internal processes may allow contamination between products manufactured and packaged on the same equipment, including the packaging of pills. the FDA wants everyone to make sure they only received the proper medication inside their packages. Several over the counter medications manufactured at the same plant have been recalled (see Novartis recall), due to the cross contamination risk.

Please help raise awareness – Tweet or post to Facebook:

Check your Meds - potential for mix up at Endo factory (Opana, Percocet, etc)
Facebook

Endo has published a visual guide for proper pill identification.

 

Resources:

Trackbacks

  1. […] prescription medications manufactured by Endo Pharmaceuticals. Please see our coverage of the Endo Advisory and check your […]

Speak Your Mind

*

You are reading the category "News - News and Current Events on topics related to drugs, alcohol, use, misuse, abuse, detox, rehabilitation, and recovery." Tell us what you think about this category.